F C Lampe

Summary

Affiliation: University College London
Country: UK

Publications

  1. pmc Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy
    Fiona C Lampe
    Research Department of Infection and Population Health, University College London, London, United Kingdom
    J Acquir Immune Defic Syndr 54:275-84. 2010
  2. pmc Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men
    Fiona C Lampe
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London NW3 2PF
    BMJ 330:1046. 2005
  3. doi Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy
    Fiona C Lampe
    Department of Infection and Population Health, University College London Medical School, London, UK
    J Acquir Immune Defic Syndr 54:500-5. 2010
  4. ncbi Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002
    Fiona C Lampe
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, England
    Arch Intern Med 166:521-8. 2006
  5. ncbi Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004
    Fiona C Lampe
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Hospital, Rowland Hill Street, London, England
    Arch Intern Med 167:692-700. 2007
  6. ncbi Variability of angina symptoms and the risk of major ischemic heart disease events
    F C Lampe
    Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, United Kingdom
    Am J Epidemiol 153:1173-82. 2001
  7. pmc Is the prevalence of coronary heart disease falling in British men?
    F C Lampe
    Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free and UCL Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK
    Heart 86:499-505. 2001
  8. doi Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression
    C J Smith
    Research Department of Infection and Population Health, Royal Free and University College Medical School, London, UK
    HIV Med 10:19-27. 2009
  9. ncbi Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free Hospital
    C J Smith
    Royal Free Centre for HIV Medicine and Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Rowland Hill Street, London, UK
    HIV Med 8:55-63. 2007
  10. ncbi North-south gradients in Britain for stroke and CHD: are they explained by the same factors?
    R W Morris
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London NW3 2PF UK
    Stroke 34:2604-9. 2003

Detail Information

Publications33

  1. pmc Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy
    Fiona C Lampe
    Research Department of Infection and Population Health, University College London, London, United Kingdom
    J Acquir Immune Defic Syndr 54:275-84. 2010
    ..We examined short-term changes in lipids and lipoprotein particles among 332 HIV-infected individuals randomized to interrupt or continue ART in the "Strategies for Management of Antiretroviral Therapy" trial...
  2. pmc Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men
    Fiona C Lampe
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London NW3 2PF
    BMJ 330:1046. 2005
    ..To examine trends over time in rates of different forms of diagnosed coronary heart disease among British men, during a period in which mortality due to coronary heart disease has been declining...
  3. doi Physical and psychological symptoms and risk of virologic rebound among patients with virologic suppression on antiretroviral therapy
    Fiona C Lampe
    Department of Infection and Population Health, University College London Medical School, London, UK
    J Acquir Immune Defic Syndr 54:500-5. 2010
    ..We examined the association of self-reported physical and psychological symptoms with subsequent virologic rebound among patients with viral suppression on combination antiretroviral therapy (cART)...
  4. ncbi Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002
    Fiona C Lampe
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, England
    Arch Intern Med 166:521-8. 2006
    ..We examined risk of initial virological failure of CART according to the year of starting therapy...
  5. ncbi Success of clinical care for human immunodeficiency virus infection according to demographic group among sexually infected patients in a routine clinic population, 1999 to 2004
    Fiona C Lampe
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Hospital, Rowland Hill Street, London, England
    Arch Intern Med 167:692-700. 2007
    ..The success of clinical care for human immunodeficiency virus infection may vary across demographic groups, because of patient- and health care-related factors...
  6. ncbi Variability of angina symptoms and the risk of major ischemic heart disease events
    F C Lampe
    Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London, United Kingdom
    Am J Epidemiol 153:1173-82. 2001
    ..In middle-aged men, exertional chest pain is a strong indicator of major coronary risk but frequently appears transient in the longer term. Persistently reported symptoms are associated with severe disease and a poor prognosis...
  7. pmc Is the prevalence of coronary heart disease falling in British men?
    F C Lampe
    Cardiovascular Research Unit, Department of Primary Care and Population Sciences, Royal Free and UCL Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK
    Heart 86:499-505. 2001
    ..To assess whether long term trends over time in acute coronary heart disease (CHD) event rates have influenced the burden of prevalent CHD in British men...
  8. doi Factors associated with viral rebound among highly treatment-experienced HIV-positive patients who have achieved viral suppression
    C J Smith
    Research Department of Infection and Population Health, Royal Free and University College Medical School, London, UK
    HIV Med 10:19-27. 2009
    ..More and more highly treatment-experienced patients are achieving viral suppression. However, the durability of suppression remains unclear...
  9. ncbi Treatment outcomes amongst previously antiretroviral-naïve HIV-infected patients starting lopinavir/ritonavir-containing antiretroviral regimens at the Royal Free Hospital
    C J Smith
    Royal Free Centre for HIV Medicine and Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Rowland Hill Street, London, UK
    HIV Med 8:55-63. 2007
    ..To describe outcomes in patients starting first-line antiretroviral regimens including lopinavir/ritonavir (LPV/r) in a routine clinic setting...
  10. ncbi North-south gradients in Britain for stroke and CHD: are they explained by the same factors?
    R W Morris
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, London NW3 2PF UK
    Stroke 34:2604-9. 2003
    ..The geographic variation in CHD and stroke within Great Britain is well known. We aimed to quantify these variations and to determine the contribution of established risk factors...
  11. pmc Geographic variation in incidence of coronary heart disease in Britain: the contribution of established risk factors
    R W Morris
    Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF, UK
    Heart 86:277-83. 2001
    ..To determine the extent to which geographic variation in the incidence of major coronary heart disease (CHD) in Great Britain may be explained by established risk factors...
  12. doi Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression
    V Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, London, UK
    HIV Med 11:216-24. 2010
    ..The aim of the study was to assess whether a simple, routinely available measure of antiretroviral therapy (ART) adherence predicts viral rebound at the next HIV viral load (VL) measurement in virally suppressed patients...
  13. ncbi No association between HIV disease and its treatment and thyroid function
    S Madge
    Royal Free Centre for HIV Medicine and Department of Primary Care and Population Sciences, Royal Free and UC Medical School, Rowland Hill Street, London, UK
    HIV Med 8:22-7. 2007
    ....
  14. doi Doctor-patient concordance during HIV treatment switching decision-making
    C Clucas
    University College London, London, UK
    HIV Med 12:87-96. 2011
    ..The aim of the study was to explore levels of doctor-patient concordance during the making of decisions regarding HIV treatment switching and stopping in relation to patient health-related outcomes...
  15. ncbi Non-attendance at re-examination 20 years after screening in the British Regional Heart Study
    M C Thomas
    Department of Primary College Medical School, Rowland Hill Street, London NW3 2PF
    J Public Health Med 24:285-91. 2002
    ....
  16. doi Self-reported non-adherence to ART and virological outcome in a multiclinic UK study
    L Sherr
    Research Department of Infection and Population Health, University College London, London, UK
    AIDS Care 22:939-45. 2010
    ..Age should be an important consideration in clinical strategies to minimise non-adherence and in decisions regarding ART initiation. A simple measure of non-adherence can identify patients at risk of poorer virological outcome...
  17. ncbi Impact of therapeutic immunization on HIV-1 viremia after discontinuation of antiretroviral therapy initiated during acute infection
    Sabine Kinloch-de Loes
    Department of Medicine, Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, London, United Kingdom
    J Infect Dis 192:607-17. 2005
    ..Our trial design appears to be feasible and safe for testing future immune-boosting strategies...
  18. ncbi Assessments for oxygen therapy in COPD: are we under correcting arterial oxygen tensions?
    K Dheda
    Dept of Respiratory and HIV Medicine, Royal Free Hospital, Pond Street, London, UK
    Eur Respir J 24:954-7. 2004
    ..The common practice of using wall-oxygen to perform assessments significantly underestimates the required oxygen-concentrator flow rate. This may have implications for the long-term effect of domiciliary oxygen therapy...
  19. doi Stability of antiretroviral regimens in patients with viral suppression
    Rebecca K Lodwick
    Research Department of Infection and Population Health, Division of Population Health, Royal Free and University College Medical School, London, UK
    AIDS 22:1039-46. 2008
    ..To study the rate of treatment change due to toxicities in patients who achieved viral suppression within 6 months of starting antiretroviral therapy and who have never experienced virological failure...
  20. doi Long-term trends in adherence to antiretroviral therapy from start of HAART
    Valentina Cambiano
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, Royal Free Campus, London, UK
    AIDS 24:1153-62. 2010
    ..We aimed to investigate long-term trends in highly active antiretroviral therapy (HAART) adherence to identify the main predictors and to evaluate whether participants experience periods of low adherence (<or=60%)...
  21. doi Ongoing changes in HIV RNA levels during untreated HIV infection: implications for CD4 cell count depletion
    Andrew N Phillips
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, Royal Free Campus, UCL Royal Free Campus, London, UK
    AIDS 24:1561-7. 2010
    ..Understanding of the interplay between plasma HIV RNA level and CD4 cell count depletion in untreated infection remains incomplete...
  22. ncbi Response to efavirenz-containing regimens in previously antiretroviral-naive HIV-positive patients: the role of gender
    Colette J Smith
    HIV Biostatistics and Epidemiology Group and Department of Primary Care and Population Science, Royal Free and University College Medical School, London, United Kingdom
    J Acquir Immune Defic Syndr 46:62-7. 2007
    ..We investigated the role of gender on response to efavirenz (EFV)-containing regimens in previously antiretroviral-naive patients...
  23. ncbi Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy
    Colette J Smith
    Royal Free Centre for HIV Medicine and Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, London, United Kingdom
    J Infect Dis 190:1860-8. 2004
    ..We sought to investigate the factors associated with increases in CD4 cell count among human immunodeficiency virus (HIV)-positive antiretroviral-naive patients starting HAART...
  24. ncbi Effect of transient antiretroviral treatment during acute HIV infection: comparison of the Quest trial results with CASCADE natural history study
    Fiona C Lampe
    Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, London, UK
    Antivir Ther 12:189-93. 2007
    ..6 years, and 17.7% (95% confidence interval [CI]: 10.9-27.6) fulfilled the primary endpoint of VL < or =1,000 copies/ml 24 weeks after CART discontinuation...
  25. ncbi Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers
    Caroline A Sabin
    Department of Primary Care and Population Sciences, Royal Free and UC Medical School, Pond St, London, UK
    AIDS 20:67-71. 2006
    ..To describe the characteristics of deaths that occur among HIV-positive individuals in the HAART era...
  26. ncbi The relationship between CD4 cell count nadirs and the toxicity profiles of antiretroviral regimens
    J Smith Colette
    Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Hospital, London, UK
    Antivir Ther 10:459-67. 2005
    ..We investigated the relationship between the pre-HAART CD4 count nadir, HAART and the occurrence of laboratory-defined toxicities...
  27. ncbi Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy
    Caroline A Sabin
    Royal Free and University College Medical School, Royal Free NHS Trust, London, UK
    AIDS 18:2145-51. 2004
    ..To investigate the characteristics and clinical, immunological and virological outcomes for individuals presenting for care with low CD4 cell counts...
  28. ncbi Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy
    Keertan Dheda
    Department of Thoracic and HIV Medicine, Royal Free Hospital, Royal Free and University College London Medical School, London, United Kingdom
    J Infect Dis 190:1670-6. 2004
    ..The benefit of highly active antiretroviral therapy (HAART) in the treatment of patients coinfected with tuberculosis (TB) and human immunodeficiency virus (HIV) is unclear because of concerns about treatment-related complications...
  29. ncbi The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy
    Colette J Smith
    Royal Free Centre for HIV Medicine and Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Royal Free Campus, London, UK
    AIDS 17:963-9. 2003
    ..To study the long-term CD4 cell responses to highly active antiretroviral therapy (HAART) in treatment-naive patients whose viral loads remained below 500 copies/ml for prolonged periods...
  30. ncbi An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment use
    C A Sabin
    Royal Free Centre for HIV Medicine, Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Rowland Hill Street, London, UK
    HIV Med 4:87-93. 2003
    ..To audit the use of antiretroviral (ARV) treatment in a large treatment clinic in the UK against the British HIV Association (BHIVA) ARV treatment guidelines...
  31. ncbi Viral breakthrough after suppression with highly active antiretroviral therapy: experience from 233 individuals with viral loads of less than 50 copies/ml followed for up to 4 years
    Fiona C Lampe
    Royal Free Centre for HIV Medicine, London, UK
    AIDS 17:768-70. 2003
  32. ncbi QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population
    N Chapman
    Peart Rose Clinic and Department of Clinical Pharmacology, Imperial College School of Medicine at St Mary s, London, United Kingdom
    Am J Hypertens 14:455-62. 2001
    ..However, as an isolated measure it was no better than simple ECG voltage criteria as a screening test for LVH in clinical practice...
  33. ncbi Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005
    Bruno Hoen
    Department of Infectious Diseases, University Medical Centre, Besancon, France
    Clin Infect Dis 45:381-90. 2007
    ..Initiation of antiretroviral therapy during primary human immunodeficiency virus (HIV)-1 infection may confer long-term benefit...